The Rift Valley Fever virus (RVFV) presents an epidemic and epizootic threat in sub-Saharan Africa, Egypt, and the Arabian Peninsula, and has furthermore recently gained attention as a potential weapon of bioterrorism due to its ability to infect both livestock and humans. Inbred rat strains show similar characteristic responses to the disease as humans and livestock, making them a suitable model species. Previous studies had indicated differences in susceptibility to RVFV hepatic disease among various rat strains, including a higher susceptibility of Wistar-Furth (WF) compared to a more resistant Lewis (LEW) strain. Further study revealed that this resistance trait exhibits the pattern of a major dominant gene inherited in Mendelian fashion. A genome scan of a congenic WF.LEW strain, created from the susceptible WF and resistant LEW strains and itself resistant to infection with RVFV, revealed 2 potential regions for the location of the gene, 1 on chromosome 3 and the other on chromosome 9. Through backcrossing of WF.LEW rats to WF rats, genotyping offspring using SNPs and microsatellites, and viral challenges of 3 N1 litters, we have mapped the gene to the distal end of chromosome 3.
led to concerns about the introduction of RVF into RVF-free countries, prompting warnings and preventive measures from numerous national and international agencies (Pfeiffer et al. 2005; Zabransky 2005; Breiman et al. 2008; Dufour et al. 2008; Kasari et al. 2008; Martin et al. 2008; Chevalier et al. 2010; Gale et al. 2010; Pepin et al. 2010; Weaver and Reisen 2010) . As such, the disease is 1 of 3 selected for particular focus by the US Department of Homeland Security's Institute for Infectious Animal Diseases due to posing a significant risk to public health or the national economy (Institute for Infectious Animal Diseases 2012). Animal model species are important for the study of this disease, and various laboratory rat (Rattus norvegicus) strains have proven useful, as they exhibit several of the major manifestations of the disease (mild, immunizing infection, hepatitis, or fatal encephalitis) observed in humans and in livestock species (Peters and Slone 1982) . Rats additionally are the only species for which inbred strains exist which are naturally either resistant or susceptible to RVF hepatic disease. A previous study found that the disease progressed rapidly in rats of the WistarFurth (WF) strain, leading to fatal liver necrosis within 2 days of initial infection, while Lewis (LEW) rats demonstrated noticeable resistance with an 84% survival rate and fatalities instead occurring from encephalitis a full 2-3 weeks post-inoculation (Anderson et al. 1987) . Classical genetic studies indicated the resistant LEW phenotype to be governed by a single dominant gene (or possibly a closely linked gene or gene complex) inherited in a classic Mendelian manner (Anderson and Peters 1988) . A WF.LEW congenic strain resistant to RVF hepatic disease was created (Anderson et al. 1991 ) and a genome scan utilizing 137 microsatellite (or simple sequence length polymorphism, SSLP) markers to compare the congenic strain to 5 WF and LEW substrains identified LEW markers on Rattus norvegicus chromosomes 3 (RNO3) and 9 (RNO9) (Callicott et al. 2007; Callicott 2008) . These 2 chromosomal regions were further investigated with an additional 15 SSLP markers and 24 single nucleotide polymorphism (SNP) markers on RNO3 and an additional 7 SSLP markers and 8 SNP markers on RNO9 (Callicott 2008) . In total, 8 markers (5 SNPs and 3 SSLPs) defined an ~1.8 Mb LEW region on RNO3 located at 169-171 Mb between rs8158676 and rs8159722, while only 1 SSLP marker (D9Rat130) represented the RNO9 LEW region located at 20 Mb. This current study has further characterized these 2 LEW regions with additional marker comparisons and, through crossbreeding and viral challenge, has determined that RNO3 contains the gene of interest responsible for resistance to RVF hepatic disease, aiding in the future identification of this gene, the definition of its mechanism, and the development of applications for protection and countermeasures against this threatening disease. Genomic DNA of N1 rats was extracted from 0.2 cm tail snips, collected humanely from neonates, by a previously described HotSHOT protocol (Truett et al. 2000) , using a 30-min heating time in a TC-512 (Techne) thermal cycler. Sample characterization using SSLP and SNP markers was carried out by methods and protocols described in the following subsection, and N1 rats were accordingly classified into 4 haplotype groups: those possessing the LEW region of RNO3 only; those possessing the LEW region of RNO9 only; those possessing both LEW regions; and those possessing neither LEW region (Figure 1) .
Material and Methods

Generation
Subsequent viral challenge was performed in ABSL-4 containment at the University of Texas Medical Branch in Galveston, Texas, with all animals being properly transported and handled in accordance with the guidelines of the AUP referenced above. Adult rats were inoculated subcutaneously with 0.1 ml of 5 × 10 5 ZH501 strain of Rift Valley Fever virus (RVFV) for the experimental groups or with 0.1 ml Hank's Balanced Salt Solution (HBSS) diluent for negative control animals. Several commercially available inbred rat strains of known susceptibility or resistance to RVFV were tested, including LEW/SsNHsd and WF/NHsd purchased from Harlan, LEW/MolTac purchased from Taconic, and LEW/Crl and WF/CrCrl purchased from Charles River Laboratories. Additionally, WF.LEW rats, (WF.LEW × WF/NHsd)F1 hybrids, and their (WF.LEW × WF/NHSd)F1 × WF/NHsd N1 backcross offspring (identified according to the 4 haplotype classifications), all of which were obtained and produced by the previously described methods, were concurrently challenged. All rats challenged were a minimum of 10 weeks of age, as full expression of resistance is achieved at this point in development. A minimum of 5 rats were challenged of each group, including 6 rats of the haplotype group possessing no LEW genome, 8 rats of the haplotype group possessing the LEW region of RNO3 only, 6 rats of the haplotype group possessing the LEW region of RNO9 only, and 5 rats of the haplotype group possessing the LEW regions on both RNO3 and RNO9. Gross necropsy was performed on all subjects, and spleen, liver, and brain tissues were collected for histopathologic examination to confirm presence of the virus.
Statistical significance of differences in survival was assessed by the log-rank test (Bland and Altman 2004) , and hazard ratios with 95% confidence intervals (95% CI) were calculated by the log-rank approach. All statistical analyses were conducted using the GraphPad Prism 6.07 software. Entry point into the study was defined as inoculation with the virus; exit point from the study was defined as either death (the outcome of interest) or survival to the conclusion of the study at 28 days, at which point all surviving rats were humanely euthanized. Differences in survival were considered to be significant at P < 0.05. Hazard ratios and corresponding confidence intervals were undefined for all comparisons involving the N1 haplotype group possessing both LEW regions, as all subjects survived to the conclusion of the study, resulting in completely censored data for this group.
Testing Additional Markers Within 2 Genomic Regions of Interest
Genomic DNA for initial SSLP and SNP marker testing of the 6 strains was prepared from rat spleen by phenol extraction with ethanol precipitation (Moore 1996) . SSLPs and SNPs were selected using the Genome Browser of the Rat Genome Database (RGD) v3.4 Assembly (Laulederkind et al. 2013) . Established primers cited on RGD were used for 5 SSLP markers: RH140313, BI301396, D3Wox1, BF412371, and BF401071. SNP forward and reverse primers were designed using Primer3 (v. 0.4.0) (Koressaar and Remm 2007) for 13 SNP markers: rs8149191, rs8164532, rs8154944, rs8163789, rs8168846, rs8152155, rs8156398, rs8164870, rs8166193, rs8146600, rs8145897, rs8167610, and rs13457129. Each specific SNaPshot primer consisted of the 30 bases immediately 5′ to the SNP location according to RGD v3.4. A previously described method utilizing M13-tailed primers was used to streamline genotyping by SSLP markers (Boutin-Ganache et al. 2001) . Each forward SSLP primer was created with a 5′-tail of the M13 sequence. Additionally, M13 sequence primers were synthesized with a 5′ label of either 6-FAM, HEX, or NED (Applied Biosystems). For the forward primer component of each reaction, a mixture of the M13-tailed forward SSLP primer with a fluorescent-labeled M13 primer in a 1:15 ratio was used. Each SSLP was amplified by standard polymerase chain reaction (PCR) (Kramer and Coen 1995) . Each reaction consisted of 1 µl 10× PCR Buffer with 15 mM MgCl 2 , 0.5 U AmpliTaq Gold® DNA Polymerase (Applied Biosystems), 200 µM each dNTP, 250 nM each forward and reverse primer, 100 ng genomic DNA, and quantity sufficient (Q.S.) of doubledistilled water to form a 10 µl reaction. Thermal cycling parameters were set as follows: initialization at 94 °C for 10 min, followed by 35 cycles of denaturation at 94 °C for 30 s, annealing at 58 °C for 30 s, and extension at 72 °C for 30 s, ending with a final extension at 72 °C for 5 min. SNPs were genotyped utilizing the SNaPshot® Multiplex Kit (Applied Biosystems). Parameters of the initial PCR reaction were identical to those previously described for SSLP markers in both setup and thermal cycling conditions with the exception of a 60 °C annealing temperature. Postreaction products were subsequently purified using the QIAquick® PCR Purification Kit (Qiagen) according to the manufacturer's recommended protocol, adding 20 µl of double-distilled water to elute in the final step. The ensuing SNaPshot reactions consisted of 3 µl of purified PCR product, 2 µl of SNaPshot Multiplex Ready Reaction Mix, 500 nM SNaPshot primer, and Q.S. of doubledistilled water to yield a 10 µl reaction. Thermal cycling parameters for the SNaPshot reaction and following post-extension treatment with 1.0 Unit of Shrimp Alkaline Phosphatase (SAP) were set according to the manufacturer's instructions. All PCR and SNaPshot reactions were performed using either a TC-512 (Techne) or a GeneAmp PCR System 9700 (Applied Biosystems) thermal cycler. Final reaction products of both SSLP and SNaPshot reactions were analyzed using a 3130xl Genetic Analyzer (Applied Biosystems), and genotypes were visualized using GeneMapper® version 4.0 (Applied Biosystems). Data archiving was not relevant to this manuscript.
Results
In total, an additional 13 SNP markers and 5 SSLP markers from the distal end of RNO3 were tested and compared across the 6 different rat substrains to better characterize this region. Of these 18 markers, 6 SNP markers (rs8164532, rs8154944, rs8163789, rs8156398, rs8167610, and rs13457129) showed 100% segregation according to the susceptible and resistant phenotypes. This increased the total number of differential haplotype markers for the RNO3 LEW region to 14, consisting of 11 SNPs and 3 SSLPs, thus defining the region of interest more precisely (Supplementary Tables 1 and 2 ).
Viral challenge results of the N1 rats were clear and conclusive, demonstrating a statistically significant difference (P < 0.0001) in survival among the 4 haplotype groups of N1 rats. N1 rats of the haplotype group possessing only the LEW region on RNO9 showed a 0% survival rate and a median survival of 2.5 days, lasting only slightly longer than susceptible N1 rats of the haplotype group lacking both LEW regions, which also showed 0% survival and had a median survival of 2 days. Meanwhile, both haplotype groups of N1 rats possessing the LEW region on RNO3 presented a high survival rate, with those having only the RNO3 LEW region showing a 75% survival rate (with deaths delayed until the second week post-infection) and those having both the RNO3 and RNO9 LEW regions surviving at 100% (Table 1; Figure 2 ). The 75% survival rate of LEW RNO3-only N1 rats was deemed reasonably congruous (particularly taking into account sample size) with previous findings of a resistant inbred LEW strain RVFV survival rate of 84% with deaths similarly occurring in the second week post-infection (Anderson et al. 1987 ).
To further investigate and establish the implications of these findings, multiple additional pairwise and groupwise comparisons were performed according to the log-rank test (Table 2 ). The statistically significant increase in survival seen in N1 rats of the haplotype possessing both LEW regions (genetically identical to WF.LEW Figure 2 . Kaplan-Meier curve depicting N1 rat survival of Rift Valley Fever (RVF) viral challenge. Results based on a minimum of 5 rats from each haplotype group challenged with 0.1 ml of 5 × 10 5 ZH501 strain of RVF virus. P < 0.0001. All surviving rats were humanely killed on day 28. rats) as compared to N1 rats of the haplotype lacking both LEW regions (genetically identical to WF/NHsd rats) paralleled what had previously been observed in these resistant and susceptible strains, supporting the validity of these viral challenge results. Similar statistically significant increases in survival, along with strikingly low hazard ratios, were consistently observed for haplotype groups possessing the RNO3 LEW region over haplotype groups lacking the RNO3 LEW region; meanwhile, possession of the RNO9 LEW region was not found to significantly increase subject survival nor notably decrease hazard ratios. Furthermore, in direct comparison of the 2 regions, possession of the RNO3 region alone as compared to the RNO9 region alone produced a statistically significant increase in subject survival and a low hazard ratio, conclusively establishing the RNO3 LEW region as containing the major genetic source of this natural resistance. Likewise, possession of both the RNO3 and RNO9 regions versus the RNO9 region alone also significantly increased survival, but conversely, possession of both the RNO3 and RNO9 regions versus the RNO3 region alone failed to produce a significant increase in survival; thus, the LEW RNO9 region not only is not indicated to contain the major gene of interest but furthermore does not appear to significantly contribute toward viral challenge survival.
Discussion
The results of these experiments have significantly advanced our search for the genetic source of this remarkable resistance phenomenon. The various statistically significant differences in survival that these viral challenge results demonstrate definitively implicate the approximately 1.8 Mb LEW region on the distal end of RNO3 to contain the major gene responsible for this resistance to RVFV. While the higher survival rate (100%) observed in N1 rats possessing the LEW regions on both RNO3 and RNO9 over those possessing only the RNO3 LEW region (75%) possibly indicates an additive role of these 2 regions that, despite a lack of statistical support, cannot be conclusively ruled out without further investigation, it may simply be a consequence of variation in sample size between the 2 groups tested. Furthermore, the identification of 6 additional differential SNP markers in this RNO3 region has provided a more comprehensive tool for further examination. This better definition of the RNO3 LEW region will greatly aid further investigation of the genetic source of this extraordinary resistance. Currently, this prospective region contains 49 genes, none of which are obvious candidates involving host response to pathogens. Future studies will include thorough exploration of the annotated contents of this genomic region in R. norvegicus and other relevant species as well as additional breeding programs and viral challenges in order to further narrow the RNO3 LEW region to eventually elicit the purported single responsible gene and mechanism for this strikingly effective resistance to the deadly Rift Valley Fever virus.
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